Found: 7
Select item for more details and to access through your institution.
Spleen enlargement is a risk factor for thrombosis in essential thrombocythemia: Evaluation on 1,297 patients.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 3, p. 318, doi. 10.1002/ajh.24269
- By:
- Publication type:
- Article
Thrombosis and survival in essential thrombocythemia: A regional study of 1,144 patients.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 5, p. 542, doi. 10.1002/ajh.23685
- By:
- Publication type:
- Article
Role of treatment on the development of secondary malignancies in patients with essential thrombocythemia.
- Published in:
- Cancer Medicine, 2017, v. 6, n. 6, p. 1233, doi. 10.1002/cam4.1081
- By:
- Publication type:
- Article
Long term follow-up of frontline Dasatinib in older patients with chronic myeloid leukemia in chronic phase treated outside clinical trials: a real-life cohort observational study.
- Published in:
- Acta Oncologica, 2021, v. 60, n. 11, p. 1527, doi. 10.1080/0284186X.2021.1971292
- By:
- Publication type:
- Article
Chelation efficacy and erythroid response during deferasirox treatment in patients with myeloproliferative neoplasms in fibrotic phase.
- Published in:
- European Journal of Haematology, 2016, v. 96, n. 6, p. 643, doi. 10.1111/ejh.12674
- By:
- Publication type:
- Article
Determinants of frontline tyrosine kinase inhibitor choice for patients with chronic‐phase chronic myeloid leukemia: A study from the Registro Italiano LMC and Campus CML.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 17, p. 2637, doi. 10.1002/cncr.34923
- By:
- Publication type:
- Article
Safety and effectiveness of ruxolitinib in the real-world management of polycythemia vera patients: a collaborative retrospective study by pH-negative MPN latial group.
- Published in:
- Annals of Hematology, 2022, v. 101, n. 6, p. 1275, doi. 10.1007/s00277-022-04815-w
- By:
- Publication type:
- Article